Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Aktsiaselts Infortar own share acquisition transactions
-
Bitget VIP Revamp Brings Up to 67% Fee Discounts and Premium Trading Perks
-
Bitget Teams Up with Google Developer Group ETH Zurich to Accelerate Web3 and AI Skills Among Students
-
Infrastructure Dividend Split Corp. Class A Distributions
-
Real Estate Split Corp. Class A and Preferred Distributions
-
Remedy's Nutrition® Launches Mega VMT™ High-Potency Multivitamin to Revolutionize Daily Energy and Nutritional Wellness
-
Remedy's Nutrition® Launches Mega VMT™ High-Potency Multivitamin to Revolutionize Daily Energy and Nutritional Wellness
-
OBOOK Holdings Inc. (OWLS) Reports 20% Year-over-Year Growth in OwlNest Business
-
LM Funding America Announces Pricing of Registered Direct Offering for Aggregate Gross Proceeds of $6.5 Million
-
E Split Corp. Class A and Preferred Distributions
-
Amplia Enters into Second Agreement with Korean Specialist Drug Screening Company Next&Bio to Explore Combination Therapy with FAK Inhibitor and kRAS Inhibitors
-
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience
-
SEALSQ Unveils Strategic Plan for 2026-2030 to Develop Silicon-Based Quantum Computing Using CMOS-Compatible Semiconductor Technologies
-
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience
-
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
-
The Lovesac Company Publishes 2025 ESG Report
-
Amplia Enters into Second Agreement with Korean Specialist Drug Screening Company Next&Bio to Explore Combination Therapy with FAK Inhibitor and kRAS Inhibitors
-
VERSES Closes CAD$2.65 Million Convertible Debenture Unit Financing
-
Form 8.3 - Avadel Pharmaceuticals plc
-
Toobit Celebrates the Holidays with $1M Christmas Trading Showdown
-
GraniteShares Announces Weekly Distributions for its YieldBOOST FoFs ETFs: YBST and YBTY
-
NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., Launches Brands PurrGuard® and Dog Gone Odor®, EPA-registered Odor-killing Bacteria Chemistry for Companion Animals
-
GXO Appoints Karen Bomber as Chief Commercial Officer
-
West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call
-
IBN Initiates Coverage of BlockQuarry Corp.
-
Visionary Copper and Gold Mines Inc. Closes Final Tranche of Private Placement Financing
-
Sienna Completes Acquisition in the Greater Toronto Area
-
Scrum Alliance's 2025 Annual Report Signals a Shift in What Organizations Need From Agile Professionals
-
Telos Corporation Selected for Missile Defense Agency SHIELD IDIQ Contract
-
Global Mofy AI Limited Announces Closing of US$4.8 Million Private Placement Financing
-
GXO Appoints Karen Bomber as Chief Commercial Officer
-
Aether Holdings Appoints Experienced Digital Asset and Capital Markets Executive Wayne Huo as Independent Director
-
Green Rain Energy Holdings, Inc. (OTC: GREH) Announces Share Reduction, Capital Structure Optimization, Reg A Re-qualification, and Auditor Engagement to Strengthen Long-Term Shareholder Value
-
ARKO Corp. Announces Filing of Registration Statement for Proposed Initial Public Offering of its Subsidiary, ARKO Petroleum Corp.
-
Suominen establishes a restricted share unit plan for key employees
-
Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Holley Inc. (NYSE: HLLY); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office
-
Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses
-
thegeekconf 2025 Panel Puts Enterprise Focus on AI’s Practical Usage
-
VCI Global Expands Upstream into Energy Infrastructure With Up to 250MW Solar Initiative Positioned to Supply AI Data Centres in Malaysia
-
VyOS Networks Announces VyOS 1.4.4 LTS Release, Reinforcing the Universal Networking Platform for Hybrid Cloud and Edge
-
Outlook Therapeutics Reports Financial Results for Fiscal Year 2025
-
HII to Build Small Surface Combatants for US Navy
-
Glass House Brands Applauds Cannabis Reform Action
-
BLAQclouds Launches ApolloCASH on December 20, Introducing Zero-Knowledge, Single-Use Liquidity for Real-Time Cross Border Remittance
-
MB Bancorp Inc. Completes $45 Million Subordinated Notes Offering
-
Cue Biopharma Announces Pricing of $10 Million Public Offering
-
Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures
-
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
-
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager
-
DraftKings Debuts Predictions App, Entering Prediction Markets
